As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. The offer price, representing a 30% premium to the stock's ...

(Reuters) - The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private ...

WASHINGTON (Reuters) -Taiwan Semiconductor Manufacturing Co has begun producing advanced 4-nanometer chips for U.S. customers ...

WASHINGTON (Reuters) - The International Monetary Fund will forecast steady global growth and continuing disinflation when it ...

The International Civil Aviation Organization this week reported a security incident, saying a threat actor known as Natohub ...

Metsera, founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners, revealed a net ...

(Reuters) - Delta Air Lines said on Friday that departures and arrivals at its Hartsfield-Jackson Atlanta hub have resumed ...

While it did not officially support either side, the FTC offered legal analysis that could aid Musk at a Tuesday hearing in ...

WASHINGTON (Reuters) - The Internal Revenue Service said on Friday it will launch the 2025 tax filing season on Jan. 27 with ...

(Reuters) - Hewlett Packard Enterprise has struck a deal worth over $1 billion to provide Elon Musk's social media platform X ...

(Reuters) - Amazon.com is ending some of its diversity and inclusion programs, the company said in a December memo to ...

XAR has an expense ratio of 0.35% and a dividend yield of 0.4%. The top five stocks in the fund include Rocket Lab USA Inc. ( ...